funder-graph

FundersORSpondyloarthritis Research and Treatment Network › 2024

Grants paid by Spondyloarthritis Research and Treatment Network, tax year 2024

EIN 46-4072112 · Portland, OR · Form 990, Schedule I · NTEE G51

In tax year 2024, Spondyloarthritis Research and Treatment Network (EIN 46-4072112) reported 5 grants paid totaling $95,000. Dataset version 2026.09.0, built 2026-09-03.

20202021202220232024

Every grant, 2024

Grants reported by Spondyloarthritis Research and Treatment Network for tax year 2024
Tax yearRecipientMatchAmountTypePurposeSource filing
2024University of Washington Seattle, WAA$25,000paidSPONDYLOARTHRITIS RESEARCH GRANT202501629349301025
2024The University of Texas Health Science Center at Houston Houston, TXA$25,000paidSPONDYLOARTHRITIS RESEARCH GRANT202501629349301025
2024Oregon Health & Science University Portland, ORA$25,000paidSPONDYLOARTHRITIS RESEARCH GRANT202501629349301025
2024Chop Research Institute Philadelphia, PAA$10,000paidSPONDYLOARTHRITIS RESEARCH GRANT202501629349301025
2024The Children's Hospital Corporation Boston, MAA$10,000paidSPONDYLOARTHRITIS RESEARCH GRANT202501629349301025

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Derived from IRS Form 990 e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.